首页 > 最新文献

Exploratory research in clinical and social pharmacy最新文献

英文 中文
Sociodemographic differences in knowledge, perceptions, and intentions regarding stimulant misuse: A theory-informed national cross-sectional survey 关于兴奋剂滥用的知识、观念和意图的社会人口学差异:一项理论知情的全国横断面调查
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-09 DOI: 10.1016/j.rcsop.2025.100695
Melissa Sanders , Kathlyn Smith , Madison Holland , Erin Blythe , Daisy Doan , Hannah Higgins , Josephine Ariella Lovings , Anne Taylor , Nicholas McCormick , Brandy Davis , Lindsey Hohmann

Background

Stimulant misuse is a rising concern in the United States.

Objectives

The purpose of this study was to better understand the U.S. general public's knowledge, perceptions, and intentions regarding stimulant misuse, and to assess sociodemographic differences.

Methods

Americans age ≥ 18 were recruited for a cross-sectional, anonymous online survey using Amazon Mechanical Turk. Outcomes, guided by the Health Belief Model, included: knowledge; perceived susceptibility, severity, and benefits surrounding prescription and non-prescription stimulant use/misuse; perceived barriers to medical stimulant use and seeking help for stimulant misuse; and non-medical stimulant use intentions. Mann-Whitney U tests assessed differences across age (young adults/adults [≤44] versus middle-aged/older adults [>44]), sex, race, and urbanicity. Linear regression assessed predictors of intentions.

Results

Respondents (N = 303) were 48.2 % female, 80.2 % White, mean 43.65 years, and 84.2 % urban-residing. Stimulant knowledge was higher among females (p = 0.017) and White individuals (p = 0.043). Perceived severity of stimulant misuse was higher among >44-year-olds (p = 0.006), females (p = 0.007), and rural residents (p = 0.009), with rural residents perceiving greater susceptibility overall (p = 0.022). Barriers to seeking help for stimulant misuse were higher among ≤44-year-olds (p = 0.025), while non-medical stimulant use intentions were higher among >44-year-olds (p = 0.002), males (p < 0.001), and urban residents (p = 0.031). Perceived severity of prescription (β = −0.268; p < 0.001) and non-prescription misuse (β = −0.191; p = 0.001), non-prescription stimulant benefits (β = 0.239; p < 0.001), barriers to seeking help (β = 0.078; p = 0.026), and age (β = −0.006; p = 0.028) predicted non-medical stimulant use intentions.

Conclusions

Knowledge, perceptions, and non-medical stimulant use intentions differed across age, sex, race, and urbanicity. Future studies should explore strategies to overcome these disparities.
兴奋剂滥用在美国日益受到关注。目的本研究的目的是更好地了解美国公众对兴奋剂滥用的认识、认知和意图,并评估社会人口统计学差异。方法招募年龄≥18岁的美国人,使用Amazon Mechanical Turk进行横断面匿名在线调查。在健康信念模型的指导下,结果包括:知识;处方和非处方兴奋剂使用/滥用的易感性、严重程度和益处;医疗兴奋剂使用和寻求兴奋剂滥用帮助方面的障碍;以及非医用兴奋剂的使用意图。Mann-Whitney U测试评估了不同年龄(年轻人/成年人[≤44]vs中年/老年人[>;44])、性别、种族和城市的差异。线性回归评估了意图的预测因子。结果303人,女性48.2%,白人80.2%,平均年龄43.65岁,城市居民84.2%。兴奋剂知识在女性(p = 0.017)和白人(p = 0.043)中较高。44岁(p = 0.006)、女性(p = 0.007)和农村居民(p = 0.009)对兴奋剂滥用严重程度的感知更高,农村居民总体上对兴奋剂滥用的易感性更高(p = 0.022)。对于兴奋剂滥用寻求帮助的障碍在≤44岁人群中较高(p = 0.025),而非医疗兴奋剂使用意愿在≤44岁人群(p = 0.002)、男性(p < 0.001)和城市居民(p = 0.031)中较高。感知到的处方严重程度(β = - 0.268; p < 0.001)和非处方滥用(β = - 0.191; p = 0.001)、非处方兴奋剂的益处(β = 0.239; p < 0.001)、寻求帮助的障碍(β = 0.078; p = 0.026)和年龄(β = - 0.006; p = 0.028)预测了非医疗兴奋剂的使用意图。结论:知识、认知和非医学兴奋剂使用意图在年龄、性别、种族和城市中存在差异。未来的研究应探索克服这些差异的策略。
{"title":"Sociodemographic differences in knowledge, perceptions, and intentions regarding stimulant misuse: A theory-informed national cross-sectional survey","authors":"Melissa Sanders ,&nbsp;Kathlyn Smith ,&nbsp;Madison Holland ,&nbsp;Erin Blythe ,&nbsp;Daisy Doan ,&nbsp;Hannah Higgins ,&nbsp;Josephine Ariella Lovings ,&nbsp;Anne Taylor ,&nbsp;Nicholas McCormick ,&nbsp;Brandy Davis ,&nbsp;Lindsey Hohmann","doi":"10.1016/j.rcsop.2025.100695","DOIUrl":"10.1016/j.rcsop.2025.100695","url":null,"abstract":"<div><h3>Background</h3><div>Stimulant misuse is a rising concern in the United States.</div></div><div><h3>Objectives</h3><div>The purpose of this study was to better understand the U.S. general public's knowledge, perceptions, and intentions regarding stimulant misuse, and to assess sociodemographic differences.</div></div><div><h3>Methods</h3><div>Americans age ≥ 18 were recruited for a cross-sectional, anonymous online survey using Amazon Mechanical Turk. Outcomes, guided by the Health Belief Model, included: knowledge; perceived susceptibility, severity, and benefits surrounding prescription and non-prescription stimulant use/misuse; perceived barriers to medical stimulant use and seeking help for stimulant misuse; and non-medical stimulant use intentions. Mann-Whitney <em>U</em> tests assessed differences across age (young adults/adults [≤44] versus middle-aged/older adults [&gt;44]), sex, race, and urbanicity. Linear regression assessed predictors of intentions.</div></div><div><h3>Results</h3><div>Respondents (<em>N</em> = 303) were 48.2 % female, 80.2 % White, mean 43.65 years, and 84.2 % urban-residing. Stimulant knowledge was higher among females (<em>p</em> = 0.017) and White individuals (<em>p</em> = 0.043). Perceived severity of stimulant misuse was higher among &gt;44-year-olds (<em>p</em> = 0.006), females (<em>p</em> = 0.007), and rural residents (<em>p</em> = 0.009), with rural residents perceiving greater susceptibility overall (<em>p</em> = 0.022). Barriers to seeking help for stimulant misuse were higher among ≤44-year-olds (<em>p</em> = 0.025), while non-medical stimulant use intentions were higher among &gt;44-year-olds (<em>p</em> = 0.002), males (<em>p</em> &lt; 0.001), and urban residents (<em>p</em> = 0.031). Perceived severity of prescription (β = −0.268; p &lt; 0.001) and non-prescription misuse (β = −0.191; <em>p</em> = 0.001), non-prescription stimulant benefits (β = 0.239; p &lt; 0.001), barriers to seeking help (β = 0.078; <em>p</em> = 0.026), and age (β = −0.006; <em>p</em> = 0.028) predicted non-medical stimulant use intentions.</div></div><div><h3>Conclusions</h3><div>Knowledge, perceptions, and non-medical stimulant use intentions differed across age, sex, race, and urbanicity. Future studies should explore strategies to overcome these disparities.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"21 ","pages":"Article 100695"},"PeriodicalIF":1.8,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145790431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of Defined Daily Dose (DDD) and antibiotic problems in Intensive Care Unit (ICU) patients 重症监护病房(ICU)患者限定日剂量(DDD)及抗生素问题分析
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-07 DOI: 10.1016/j.rcsop.2025.100688
Yulistiani Yulistiani , Hargus Haraudi Barkah , Febriansyah Nur Utomo , Lucky Andrianto , Alena Putri Jathi , Nurrizky Grahitaning Putra Rohmaana Yudistira

Background

The increasing prevalence of antimicrobial resistance (AMR) in Intensive Care Unit (ICU) is posing a significant challenge to effective infection management. This shows the need for quantitative evaluation of antibiotic use through the Defined Daily Dose (DDD) method, combined with Drug Related Problems (DRPs) analysis to support Antimicrobial Stewardship (AMS) programs. Therefore, this study aimed to analyze the quantitative use of antibiotic using DDD method and identify DRP in ICU patients at Airlangga University Hospital. A retrospective cross-sectional study was conducted using medical records of ICU patients from July to December 2022. Antibiotic consumption was calculated in DDD per 100 patient-days following WHO standards, while DRPs were identified using the Cipolle and Pharmaceutical Care Network Europe (PCNE) v9.1 classifications. A total of 125 ICU patients met the inclusion criteria, with a predominance of pneumonia (40 %) and sepsis (25 %). The results showed that the total antibiotic consumption was 91.54 DDD/100 patient-days, with ceftriaxone having the highest (31.57 DDD/100 patient-days). The most frequent DRPs were unnecessary drug therapy (20 %) and suboptimal therapeutic effects (23 %), mainly due to inappropriate indications and deviations from treatment guidelines. Antibiotic use in ICU was dominated by ceftriaxone, and the high rate of DRPs showed the need for improved AMS. This study showed that strengthening interdisciplinary collaboration, regular audits, and adherence to clinical guidelines were essential steps to optimize antibiotic use and minimize the risk of resistance.
重症监护病房(ICU)抗菌素耐药性(AMR)的日益流行对有效的感染管理提出了重大挑战。这表明需要通过限定日剂量(DDD)方法对抗生素使用进行定量评估,并结合药物相关问题(DRPs)分析,以支持抗菌药物管理(AMS)计划。因此,本研究旨在利用DDD法分析艾朗加大学医院ICU患者抗生素的定量使用情况,并对DRP进行鉴定。对2022年7月至12月ICU患者病历进行回顾性横断面研究。按照世卫组织标准,以每100患者日的DDD计算抗生素消费量,而使用Cipolle和欧洲药物保健网络(PCNE) v9.1分类确定抗菌素。共有125例ICU患者符合纳入标准,以肺炎(40%)和败血症(25%)为主。结果显示,该院抗菌药物总用量为91.54 DDD/100患者-d,其中头孢曲松用量最高,为31.57 DDD/100患者-d。最常见的drp是不必要的药物治疗(20%)和治疗效果不理想(23%),主要是由于适应症不适当和偏离治疗指南。ICU的抗生素使用以头孢曲松为主,高DRPs率表明需要改进AMS。这项研究表明,加强跨学科合作、定期审核和遵守临床指南是优化抗生素使用和最大限度地减少耐药风险的必要步骤。
{"title":"Analysis of Defined Daily Dose (DDD) and antibiotic problems in Intensive Care Unit (ICU) patients","authors":"Yulistiani Yulistiani ,&nbsp;Hargus Haraudi Barkah ,&nbsp;Febriansyah Nur Utomo ,&nbsp;Lucky Andrianto ,&nbsp;Alena Putri Jathi ,&nbsp;Nurrizky Grahitaning Putra Rohmaana Yudistira","doi":"10.1016/j.rcsop.2025.100688","DOIUrl":"10.1016/j.rcsop.2025.100688","url":null,"abstract":"<div><h3>Background</h3><div>The increasing prevalence of antimicrobial resistance (AMR) in Intensive Care Unit (ICU) is posing a significant challenge to effective infection management. This shows the need for quantitative evaluation of antibiotic use through the Defined Daily Dose (DDD) method, combined with Drug Related Problems (DRPs) analysis to support Antimicrobial Stewardship (AMS) programs. Therefore, this study aimed to analyze the quantitative use of antibiotic using DDD method and identify DRP in ICU patients at Airlangga University Hospital. A retrospective cross-sectional study was conducted using medical records of ICU patients from July to December 2022. Antibiotic consumption was calculated in DDD per 100 patient-days following WHO standards, while DRPs were identified using the Cipolle and Pharmaceutical Care Network Europe (PCNE) v9.1 classifications. A total of 125 ICU patients met the inclusion criteria, with a predominance of pneumonia (40 %) and sepsis (25 %). The results showed that the total antibiotic consumption was 91.54 DDD/100 patient-days, with ceftriaxone having the highest (31.57 DDD/100 patient-days). The most frequent DRPs were unnecessary drug therapy (20 %) and suboptimal therapeutic effects (23 %), mainly due to inappropriate indications and deviations from treatment guidelines. Antibiotic use in ICU was dominated by ceftriaxone, and the high rate of DRPs showed the need for improved AMS. This study showed that strengthening interdisciplinary collaboration, regular audits, and adherence to clinical guidelines were essential steps to optimize antibiotic use and minimize the risk of resistance.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"21 ","pages":"Article 100688"},"PeriodicalIF":1.8,"publicationDate":"2025-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research self-efficacy in early-career pharmacists: Tool validation and correlation with personal attributes 早期职业药师自我效能感的研究:工具验证及其与个人属性的相关性
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-06 DOI: 10.1016/j.rcsop.2025.100693
Aline Hajj , Hala Sacre , Chadia Haddad , Jenny Elia , Joya El Ghawi , Lina Haidar , Lama Dimachkieh , Mahmoud Nasrallah , Jihan Safwan , Deema Rahme , Sukaina Basma , Salameh Pascale

Introduction

Self-efficacy in research and personal characteristics of pharmacists are necessary to lead and implement pharmaceutical research strategies. This study primarily aimed to confirm the validity of the Research Self-Efficacy Scale (RSES) among early-career pharmacists; a secondary objective was to assess participants' perspectives on research self-efficacy while considering personal characteristics, such as strategic thinking and leadership.

Methods

Using an exploratory factor analysis and internal consistency measure, the RSES scale validity and reliability were assessed among Lebanese early-career pharmacists. Its association with personal attributes, such as global self-efficacy, leadership, and strategic thinking, was also assessed through correlation with validated measures.

Results

The RSES scale was found to be valid and reliable. Pharmacists from foreign universities scored higher on the RSES compared to their counterparts from Lebanese institutions. Additionally, a positive correlation was found between self-efficacy, generalized self-efficacy, and strategic thinking scores, while differences between universities and year of study did not reach statistical significance.

Conclusion

This study demonstrated that the RSES is a valid and reliable tool for assessing research self-efficacy among early-career pharmacists in Lebanon. Several strategies could be implemented at the institutional and national levels to strengthen self-efficacy and cultivate a sustainable research environment. These include enhancing educational frameworks, integrating research opportunities, and fostering international collaborations. Future research using this validated scale will be instrumental in evaluating the effectiveness of such interventions.
研究自我效能感和药师的个人特征是领导和实施药物研究策略的必要条件。本研究旨在验证研究自我效能量表(RSES)在早期职业药师中的效度;第二个目标是评估参与者对研究自我效能的看法,同时考虑个人特征,如战略思维和领导力。方法采用探索性因子分析和内部一致性测量法,对黎巴嫩早期职业药师的RSES量表进行效度和信度评估。它与个人属性的关联,如全球自我效能、领导力和战略思维,也通过与验证措施的相关性进行了评估。结果RSES量表有效、可靠。来自外国大学的药剂师比来自黎巴嫩机构的同行在RSES上得分更高。此外,自我效能感、广义自我效能感与策略思维得分呈正相关,而大学和年级之间的差异无统计学意义。结论本研究表明,RSES是评估黎巴嫩早期职业药师研究自我效能感的有效、可靠的工具。可以在机构和国家两级执行若干战略,以加强自我效能和培养可持续的研究环境。这些措施包括加强教育框架、整合研究机会和促进国际合作。未来使用这一有效量表的研究将有助于评估此类干预措施的有效性。
{"title":"Research self-efficacy in early-career pharmacists: Tool validation and correlation with personal attributes","authors":"Aline Hajj ,&nbsp;Hala Sacre ,&nbsp;Chadia Haddad ,&nbsp;Jenny Elia ,&nbsp;Joya El Ghawi ,&nbsp;Lina Haidar ,&nbsp;Lama Dimachkieh ,&nbsp;Mahmoud Nasrallah ,&nbsp;Jihan Safwan ,&nbsp;Deema Rahme ,&nbsp;Sukaina Basma ,&nbsp;Salameh Pascale","doi":"10.1016/j.rcsop.2025.100693","DOIUrl":"10.1016/j.rcsop.2025.100693","url":null,"abstract":"<div><h3>Introduction</h3><div>Self-efficacy in research and personal characteristics of pharmacists are necessary to lead and implement pharmaceutical research strategies. This study primarily aimed to confirm the validity of the Research Self-Efficacy Scale (RSES) among early-career pharmacists; a secondary objective was to assess participants' perspectives on research self-efficacy while considering personal characteristics, such as strategic thinking and leadership.</div></div><div><h3>Methods</h3><div>Using an exploratory factor analysis and internal consistency measure, the RSES scale validity and reliability were assessed among Lebanese early-career pharmacists. Its association with personal attributes, such as global self-efficacy, leadership, and strategic thinking, was also assessed through correlation with validated measures.</div></div><div><h3>Results</h3><div>The RSES scale was found to be valid and reliable. Pharmacists from foreign universities scored higher on the RSES compared to their counterparts from Lebanese institutions. Additionally, a positive correlation was found between self-efficacy, generalized self-efficacy, and strategic thinking scores, while differences between universities and year of study did not reach statistical significance.</div></div><div><h3>Conclusion</h3><div>This study demonstrated that the RSES is a valid and reliable tool for assessing research self-efficacy among early-career pharmacists in Lebanon. Several strategies could be implemented at the institutional and national levels to strengthen self-efficacy and cultivate a sustainable research environment. These include enhancing educational frameworks, integrating research opportunities, and fostering international collaborations. Future research using this validated scale will be instrumental in evaluating the effectiveness of such interventions.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"21 ","pages":"Article 100693"},"PeriodicalIF":1.8,"publicationDate":"2025-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healthcare providers' perspectives on collaboration of care for acute cystitis in women and the role of the community pharmacy: A qualitative study 医疗保健提供者对妇女急性膀胱炎护理合作的看法和社区药房的作用:一项定性研究
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-06 DOI: 10.1016/j.rcsop.2025.100694
Marle Gemmeke , Maureen C. Jansen , Thomas G.H. Kempen , Marcel L. Bouvy

Introduction

Acute cystitis (AC) is generally treated in primary care by general practitioners. Support from the community pharmacy may relieve the GP's workload and increase accessibility of care for women.

Aim

To explore healthcare providers' (HCPs') perspectives on the collaboration of care for AC and investigate their views on possibilities for task shifting towards community pharmacy.

Method

This qualitative study was conducted within the setting of pharmacotherapy audit meetings (PTAMs) involving general practitioners and community pharmacists. Focus group discussions were embedded in PTAMs to gain insight into participants' perspectives on the organization of care for AC and the potential role of the community pharmacies. Additionally, individual interviews were carried out with a subset of PTAM participants and other primary care professionals (e.g. assistants). Focus groups and interviews were audio-taped, transcribed verbatim and thematically analyzed.

Results

Five focus groups and 12 interviews were conducted; in total 57 participants were included (45 of them were working in general practice). Although HCPs were experienced in providing AC care, they reported some shortcomings in the current care process. They perceived limited advantages in shifting tasks to community pharmacies. Key barriers included time constraints within pharmacies and insufficient access to patients' medical histories. Expanding the role of community pharmacies could be supported through financial compensation for counseling, adequate training of pharmacy personnel, and strong collaboration between pharmacists and general practitioners.

Conclusion

Although there is room for improvement in the organization of care for AC, participants saw limited opportunities for task shifting towards community pharmacy.
急性膀胱炎(AC)通常由全科医生在初级保健中治疗。社区药房的支持可以减轻全科医生的工作量,增加妇女获得护理的机会。目的探讨医疗保健提供者(HCPs)对合作护理AC的观点,并调查他们对任务转移到社区药房的可能性的看法。方法采用全科医生和社区药师参加的药物治疗审核会议(PTAMs)进行定性研究。焦点小组讨论嵌入到ptm中,以深入了解参与者对AC护理组织和社区药房潜在作用的看法。此外,对一部分PTAM参与者和其他初级保健专业人员(如助理)进行了个别访谈。对焦点小组和访谈进行录音,逐字记录,并按主题进行分析。结果共进行了5个焦点小组和12次访谈;总共包括57名参与者(其中45人从事全科工作)。尽管hcp在提供AC护理方面经验丰富,但他们报告了目前护理过程中的一些缺点。他们认为将任务转移到社区药房的好处有限。主要障碍包括药房的时间限制和无法获得病人的病史。扩大社区药房的作用可以通过对咨询的经济补偿、对药学人员的充分培训以及药剂师和全科医生之间的强有力合作得到支持。结论:虽然AC的护理组织有改进的空间,但参与者认为任务转移到社区药房的机会有限。
{"title":"Healthcare providers' perspectives on collaboration of care for acute cystitis in women and the role of the community pharmacy: A qualitative study","authors":"Marle Gemmeke ,&nbsp;Maureen C. Jansen ,&nbsp;Thomas G.H. Kempen ,&nbsp;Marcel L. Bouvy","doi":"10.1016/j.rcsop.2025.100694","DOIUrl":"10.1016/j.rcsop.2025.100694","url":null,"abstract":"<div><h3>Introduction</h3><div>Acute cystitis (AC) is generally treated in primary care by general practitioners. Support from the community pharmacy may relieve the GP's workload and increase accessibility of care for women.</div></div><div><h3>Aim</h3><div>To explore healthcare providers' (HCPs') perspectives on the collaboration of care for AC and investigate their views on possibilities for task shifting towards community pharmacy.</div></div><div><h3>Method</h3><div>This qualitative study was conducted within the setting of pharmacotherapy audit meetings (PTAMs) involving general practitioners and community pharmacists. Focus group discussions were embedded in PTAMs to gain insight into participants' perspectives on the organization of care for AC and the potential role of the community pharmacies. Additionally, individual interviews were carried out with a subset of PTAM participants and other primary care professionals (e.g. assistants). Focus groups and interviews were audio-taped, transcribed verbatim and thematically analyzed.</div></div><div><h3>Results</h3><div>Five focus groups and 12 interviews were conducted; in total 57 participants were included (45 of them were working in general practice). Although HCPs were experienced in providing AC care, they reported some shortcomings in the current care process. They perceived limited advantages in shifting tasks to community pharmacies. Key barriers included time constraints within pharmacies and insufficient access to patients' medical histories. Expanding the role of community pharmacies could be supported through financial compensation for counseling, adequate training of pharmacy personnel, and strong collaboration between pharmacists and general practitioners.</div></div><div><h3>Conclusion</h3><div>Although there is room for improvement in the organization of care for AC, participants saw limited opportunities for task shifting towards community pharmacy.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"21 ","pages":"Article 100694"},"PeriodicalIF":1.8,"publicationDate":"2025-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145737038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring work engagement and its associated factors among supervising pharmacists in Japan 日本监管药师工作投入及其相关因素探讨
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-05 DOI: 10.1016/j.rcsop.2025.100691
Yukari Ito , Hiroko Suzuki , Tetsuro Yumoto , Sachiko Ohta , Tomoo Hosoe

Background

This study investigated the work engagement of supervising pharmacists and sought to identify factors associated with high work engagement.
Given the growing shortage of healthcare professionals in rapidly aging societies, enhancing work engagement among pharmacists is critical to improve productivity, prevent turnover, and ensure the quality of community healthcare. Supervising pharmacists weretargeted due to their pivotal role as gatekeepers between organizational leadership and frontline staff in community pharmacies.

Methods

A cross-sectional survey was conducted among supervising pharmacists from major community pharmacy chainsbetween August 2023 and September 2024. Participants completed a web-based questionnaire assessing demographic data, occupational stress, and work engagement. The associations between work engagement and related factors were evaluated using bivariate and multivariate logistic regression analyses with high work engagement defined as the top quartile of UWES-17.

Results

Data from 973 participantswere analyzed. The median UWES-17 score was 2.82. Among the three dimensions, “dedication” scored the highest. The primary factors associated with high work engagement includedperceived “meaningfulness of work”, “job control”, “suitable jobs”, “age group (≥50 years)”, “coworker support”.

Conclusion

This study suggests that the distinct roles and workplace environments of supervising pharmacists are closely linked to their work engagement. Balancing job resources and demands is critical for sustaining engagement to maintain high-quality patient care. Interventions that strengthen self-awareness, peer collaboration, and career development within “Communities of Practice” could reinforce these gains.
本研究调查了督导药师的工作投入,并试图找出高工作投入的相关因素。鉴于快速老龄化社会中医疗保健专业人员的日益短缺,加强药剂师之间的工作参与对于提高生产力、防止人员流动和确保社区医疗保健质量至关重要。监管药师作为社区药房组织领导和一线人员之间的看门人,发挥着关键作用。方法于2023年8月至2024年9月对各大社区连锁药店的监管药师进行横断面调查。参与者完成了一份基于网络的调查问卷,评估人口统计数据、职业压力和工作投入。使用双变量和多变量逻辑回归分析评估工作投入与相关因素之间的关联,并将高工作投入定义为UWES-17的前四分位数。结果973名参与者的数据被分析。UWES-17评分中位数为2.82。在三个维度中,“奉献精神”得分最高。与高工作投入相关的主要因素包括感知“工作意义”、“工作控制”、“合适的工作”、“年龄(≥50岁)”、“同事支持”。结论督导药师的不同角色和工作环境与督导药师的工作投入密切相关。平衡工作资源和需求对于维持高质量的患者护理至关重要。在“实践社区”内加强自我意识、同伴协作和职业发展的干预措施可以加强这些成果。
{"title":"Exploring work engagement and its associated factors among supervising pharmacists in Japan","authors":"Yukari Ito ,&nbsp;Hiroko Suzuki ,&nbsp;Tetsuro Yumoto ,&nbsp;Sachiko Ohta ,&nbsp;Tomoo Hosoe","doi":"10.1016/j.rcsop.2025.100691","DOIUrl":"10.1016/j.rcsop.2025.100691","url":null,"abstract":"<div><h3>Background</h3><div>This study investigated the work engagement of supervising pharmacists and sought to identify factors associated with high work engagement.</div><div>Given the growing shortage of healthcare professionals in rapidly aging societies, enhancing work engagement among pharmacists is critical to improve productivity, prevent turnover, and ensure the quality of community healthcare. Supervising pharmacists weretargeted due to their pivotal role as gatekeepers between organizational leadership and frontline staff in community pharmacies.</div></div><div><h3>Methods</h3><div>A cross-sectional survey was conducted among supervising pharmacists from major community pharmacy chainsbetween August 2023 and September 2024. Participants completed a web-based questionnaire assessing demographic data, occupational stress, and work engagement. The associations between work engagement and related factors were evaluated using bivariate and multivariate logistic regression analyses with high work engagement defined as the top quartile of UWES-17.</div></div><div><h3>Results</h3><div>Data from 973 participantswere analyzed. The median UWES-17 score was 2.82. Among the three dimensions, “dedication” scored the highest. The primary factors associated with high work engagement includedperceived “meaningfulness of work”, “job control”, “suitable jobs”, “age group (≥50 years)”, “coworker support”.</div></div><div><h3>Conclusion</h3><div>This study suggests that the distinct roles and workplace environments of supervising pharmacists are closely linked to their work engagement. Balancing job resources and demands is critical for sustaining engagement to maintain high-quality patient care. Interventions that strengthen self-awareness, peer collaboration, and career development within “Communities of Practice” could reinforce these gains.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"21 ","pages":"Article 100691"},"PeriodicalIF":1.8,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patients' perspectives and experiences regarding medication reviews: A cross-sectional survey study 患者对药物评价的看法和经验:一项横断面调查研究
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-05 DOI: 10.1016/j.rcsop.2025.100692
Charlotte Falke , Fatma Karapinar-Çarkit , Wilma Knol , Marcel Bouvy , Toine Egberts , Thomas Kempen , Marcia Vervloet , Mette Heringa

Background

Medication reviews are conducted worldwide to reduce medication-related problems. However, real-world patient perspectives and experiences remain underexplored. This study aimed to explore patients' perspectives and experiences regarding medication reviews and to assess differences across levels of polypharmacy.

Methods

A cross-sectional online survey was conducted among a panel of Dutch pharmacy visitors. Topics included perspectives and experiences regarding medication reviews. Descriptive statistics were used, and Chi-square tests were used to assess differences between levels of polypharmacy (non-polypharmacy: 1–4 medications; polypharmacy: 5–9 medications; hyperpolypharmacy: ≥10 medications).

Results

Among 4395 respondents (median age: 71; 43 % female), 48 % were aware of the existence of medication reviews, and 85 % deemed these important. Patients valued discussing the appropriateness, efficacy, side-effects, and risks of medication more than practical medication-related issues. These perspectives were consistent across polypharmacy levels. Overall, 1176 patients (27 %) had experienced a review (non-polypharmacy: 22 %; polypharmacy: 29 %; hyperpolypharmacy: 39 %). Of these, 92 % felt able to ask questions, and 62 % felt treatment options were sufficiently discussed. Patients reported that their review resulted in better medication understanding (68 %), increased confidence in medication usage (65 %), and fewer health issues (40 %). Patients with non-polypharmacy reported improvements in follow-up agreements (9 %) and involvement of secondary healthcare providers (11 %) less frequently than those with polypharmacy (14 %/15 %) and hyperpolypharmacy (19 %/26 %).

Conclusion

Most patients valued medication reviews, yet only half were aware of their existence. Generally, levels of polypharmacy hardly impacted patient perspectives. Based on patients' experiences, shared decision-making, follow-ups, and multidisciplinary approaches could be better implemented in medication reviews.
在世界范围内进行药物审查是为了减少与药物有关的问题。然而,现实世界患者的观点和经验仍未得到充分探索。本研究旨在探讨患者对药物评价的看法和经验,并评估不同层次的综合用药的差异。方法采用横断面在线调查方法,对荷兰药店的来访人员进行调查。主题包括关于药物审查的观点和经验。采用描述性统计,并采用卡方检验评估多药水平(非多药:1-4种药物;多药:5-9种药物;多药:≥10种药物)之间的差异。结果在4395名受访者中(中位年龄:71岁,43%为女性),48%的人知道药物评价的存在,85%的人认为药物评价很重要。患者更重视讨论药物的适当性、疗效、副作用和风险,而不是实际的药物相关问题。这些观点是一致的在多药水平。总体而言,1176名患者(27%)接受了复查(非多种药物:22%;多种药物:29%;过度多种药物:39%)。其中,92%的人认为能够提出问题,62%的人认为治疗方案得到了充分的讨论。患者报告说,他们的回顾使他们更好地了解药物(68%),增加了对药物使用的信心(65%),减少了健康问题(40%)。与综合用药(14% / 15%)和综合用药(19% / 26%)的患者相比,非综合用药的患者在随访协议(9%)和二级医疗保健提供者的参与(11%)方面有所改善。结论大多数患者重视药物评价,但仅有一半患者意识到药物评价的存在。一般来说,多药水平几乎不影响患者的观点。基于患者的经验,共同决策、随访和多学科方法可以更好地在药物评审中实施。
{"title":"Patients' perspectives and experiences regarding medication reviews: A cross-sectional survey study","authors":"Charlotte Falke ,&nbsp;Fatma Karapinar-Çarkit ,&nbsp;Wilma Knol ,&nbsp;Marcel Bouvy ,&nbsp;Toine Egberts ,&nbsp;Thomas Kempen ,&nbsp;Marcia Vervloet ,&nbsp;Mette Heringa","doi":"10.1016/j.rcsop.2025.100692","DOIUrl":"10.1016/j.rcsop.2025.100692","url":null,"abstract":"<div><h3>Background</h3><div>Medication reviews are conducted worldwide to reduce medication-related problems. However, real-world patient perspectives and experiences remain underexplored. This study aimed to explore patients' perspectives and experiences regarding medication reviews and to assess differences across levels of polypharmacy.</div></div><div><h3>Methods</h3><div>A cross-sectional online survey was conducted among a panel of Dutch pharmacy visitors. Topics included perspectives and experiences regarding medication reviews. Descriptive statistics were used, and Chi-square tests were used to assess differences between levels of polypharmacy (non-polypharmacy: 1–4 medications; polypharmacy: 5–9 medications; hyperpolypharmacy: ≥10 medications).</div></div><div><h3>Results</h3><div>Among 4395 respondents (median age: 71; 43 % female), 48 % were aware of the existence of medication reviews, and 85 % deemed these important. Patients valued discussing the appropriateness, efficacy, side-effects, and risks of medication more than practical medication-related issues. These perspectives were consistent across polypharmacy levels. Overall, 1176 patients (27 %) had experienced a review (non-polypharmacy: 22 %; polypharmacy: 29 %; hyperpolypharmacy: 39 %). Of these, 92 % felt able to ask questions, and 62 % felt treatment options were sufficiently discussed. Patients reported that their review resulted in better medication understanding (68 %), increased confidence in medication usage (65 %), and fewer health issues (40 %). Patients with non-polypharmacy reported improvements in follow-up agreements (9 %) and involvement of secondary healthcare providers (11 %) less frequently than those with polypharmacy (14 %/15 %) and hyperpolypharmacy (19 %/26 %).</div></div><div><h3>Conclusion</h3><div>Most patients valued medication reviews, yet only half were aware of their existence. Generally, levels of polypharmacy hardly impacted patient perspectives. Based on patients' experiences, shared decision-making, follow-ups, and multidisciplinary approaches could be better implemented in medication reviews.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"21 ","pages":"Article 100692"},"PeriodicalIF":1.8,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Field survey on warnings to prevent drug abuse when selling over-the-counter drugs at drugstores 实地调查药店销售非处方药时防止滥用药物的警告
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-03 DOI: 10.1016/j.rcsop.2025.100690
Kazuki Nagashima, Hinata Nasu, Yuko Sekine

Objective

The abuse of over-the-counter (OTC) medications is increasing and has led to a rise in overdose cases. This study examined commonly misused OTC drugs, developed checklist items related to warnings provided during their sale, and conducted field surveys to compare practices based on whether products contained ingredients designated by the Ministry of Health, Labour and Welfare (MHLW), Japan.

Methods

An eight items checklist was developed using MHLW-specified survey items, with additional items added by the researchers. Using this checklist, a researcher evaluated OTC purchases for 25 different drugs by marking each item as positive (〇) or negative (×) from 17 drugstores.

Results

Across 25 products surveyed, the most common positive item was “explanation by a qualified person” (11 positives, 44 %), followed by “point-of-purchase (POP) warning displays” (9 positives, 36 %) and “display near the cash register” (8 positives, 32 %). For OTC drugs containing designated ingredients (n = 13), the item achievement rates were as follows: “explanation by a qualified person,” 10 positives, 77 %; “POP warning displays,” 9 positives, 69 %; “display of empty boxes,” 2 positives, 15 %; and “verbal verification of age,” 1 positive, 8 %. The aforementioned items were less likely in the case of OTC drugs without designated ingredients with potential for abuse, with the number of instances of “explanation by a qualified person” and “POP warning displays” being significantly lower (p < 0.05).

Conclusion

To intervene with targets to prevent abuse and issue warnings about OTC drugs during a sale, proactive warnings about misused OTC drugs that do not contain designated ingredients are necessary.
目的滥用非处方药物(OTC)的情况正在增加,并导致药物过量的病例增加。本研究审查了常被滥用的非处方药,制定了与销售期间提供的警告有关的清单项目,并进行了实地调查,以根据产品是否含有日本卫生、劳动和福利部指定的成分来比较做法。方法采用《卫生与社会保障法》规定的调查项目编制8项问卷,并由研究者自行补充。使用该清单,研究人员通过将17家药店的25种不同药物标记为阳性(〇)或阴性(x)来评估OTC购买情况。结果在调查的25种产品中,最常见的正面项目是“有资格的人解释”(11个阳性,44%),其次是“购买点(POP)警告显示”(9个阳性,36%)和“收银机附近显示”(8个阳性,32%)。对于指定成分的非处方药(n = 13),项目完成率如下:“有资质人员解释”,阳性10个,77%;“POP警告显示”,9个阳性,69%;“展示空盒子”,2个阳性,15%;而“口头年龄验证”,1%是肯定的,8%。在没有指定成分的非处方药中,出现上述问题的可能性较低,出现“有资质人员解释”和“POP警告显示”的次数明显较低(p < 0.05)。结论要有针对性地进行干预,防止滥用,并在销售过程中对非处方药发出警告,有必要对不含指定成分的非处方药被滥用进行主动警告。
{"title":"Field survey on warnings to prevent drug abuse when selling over-the-counter drugs at drugstores","authors":"Kazuki Nagashima,&nbsp;Hinata Nasu,&nbsp;Yuko Sekine","doi":"10.1016/j.rcsop.2025.100690","DOIUrl":"10.1016/j.rcsop.2025.100690","url":null,"abstract":"<div><h3>Objective</h3><div>The abuse of over-the-counter (OTC) medications is increasing and has led to a rise in overdose cases. This study examined commonly misused OTC drugs, developed checklist items related to warnings provided during their sale, and conducted field surveys to compare practices based on whether products contained ingredients designated by the Ministry of Health, Labour and Welfare (MHLW), Japan.</div></div><div><h3>Methods</h3><div>An eight items checklist was developed using MHLW-specified survey items, with additional items added by the researchers. Using this checklist, a researcher evaluated OTC purchases for 25 different drugs by marking each item as positive (〇) or negative (×) from 17 drugstores.</div></div><div><h3>Results</h3><div>Across 25 products surveyed, the most common positive item was “explanation by a qualified person” (11 positives, 44 %), followed by “point-of-purchase (POP) warning displays” (9 positives, 36 %) and “display near the cash register” (8 positives, 32 %). For OTC drugs containing designated ingredients (<em>n</em> = 13), the item achievement rates were as follows: “explanation by a qualified person,” 10 positives, 77 %; “POP warning displays,” 9 positives, 69 %; “display of empty boxes,” 2 positives, 15 %; and “verbal verification of age,” 1 positive, 8 %. The aforementioned items were less likely in the case of OTC drugs without designated ingredients with potential for abuse, with the number of instances of “explanation by a qualified person” and “POP warning displays” being significantly lower (<em>p</em> &lt; 0.05).</div></div><div><h3>Conclusion</h3><div>To intervene with targets to prevent abuse and issue warnings about OTC drugs during a sale, proactive warnings about misused OTC drugs that do not contain designated ingredients are necessary.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"21 ","pages":"Article 100690"},"PeriodicalIF":1.8,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145737039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prescription-only medicine requests by clients: Insights from community pharmacies 客户的处方药物要求:来自社区药房的见解
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-03 DOI: 10.1016/j.rcsop.2025.100689
Chabiya Ayuba Tashiwa , Erick Wesley Hedima

Background

The accessibility of community pharmacies increases the likelihood that patients will approach pharmacists for medication needs, including those that require prescriptions. This study assessed prescription medicine requests from members of the public. Method This study employed a cross-sectional design to investigate clients seeking medication from community pharmacies in Karu, Nasarawa State, Nigeria. Data were collected using a validated questionnaire comprising of two sections. Chi-square or Fisher's exact tests, where appropriate, were utilized to determine factors associated with prescription-only medicine (POM) requests. Associations between perception scores and patient characteristics were analyzed using the Mann-Whitney U test or Kruskal-Wallis test. Logistic regression analysis was employed to identify factors that may elucidate the correlates of obtaining medicines without a prescription. Statistical significance was set at p < 0.05 (95 % CI).

Results

A total of 258 adults with access to prescription-only (POM) or over-thecounter (OTC) medications were included in the study. The prevalence of prescription medicine request was 53 %. Headaches, fever, pain, and dysmenorrhea were the most frequent complaints (33.9 %). A significant difference was observed between medicineseeking practices and chronic illnesses (p = 0.01). The odds of requesting a POM decreased with lower educational attainment (AOR 0.05; 95 % CI, 0.06–0.43). While Age (p = 0.006), employment status (p = 0.03), and monthly income (p = 0.01) were significantly associated with perception of medication-seeking behavior. The most commonly requested medicine was artemether and lumefantrine, accounting for 12.3 % of prescriptions. Most respondents agreed that consultation with a registered medical practitioner for any health concern is necessary.

Conclusion

The prevalence of prescription-only medicine requests by clients seeking healthcare from community pharmacies was relatively high. Artemether/lumefantrine and amoxicillin/clavulanate were the most sought medicines. Strengthen national prescribing policies by granting pharmacists structured prescribing authority, thereby promoting accountability and the rational use of medicines.
社区药房的可及性增加了患者向药剂师寻求药物需求的可能性,包括那些需要处方的药物。这项研究评估了公众对处方药的要求。方法本研究采用横断面设计对尼日利亚纳萨拉瓦州卡鲁社区药房求医的顾客进行调查。数据收集使用有效的问卷调查,包括两个部分。在适当的情况下,使用卡方检验或Fisher精确检验来确定与处方药物(POM)请求相关的因素。使用Mann-Whitney U检验或Kruskal-Wallis检验分析感知评分与患者特征之间的关系。采用Logistic回归分析来确定可能阐明无处方获得药物的相关因素。p < 0.05 (95% CI)具有统计学意义。结果共有258名获得处方(POM)或非处方(OTC)药物的成年人被纳入研究。处方用药请求率为53%。头痛、发热、疼痛和痛经是最常见的主诉(33.9%)。就诊行为与慢性疾病有显著性差异(p = 0.01)。要求POM的几率随着受教育程度的降低而降低(AOR 0.05; 95% CI, 0.06-0.43)。年龄(p = 0.006)、就业状况(p = 0.03)和月收入(p = 0.01)与就医行为感知显著相关。用药最多的是蒿甲醚和苯丙啶,占处方的12.3%。大多数答复者同意,就任何健康问题向注册医生咨询是必要的。结论在社区药房就诊的患者中,单处方用药的比例较高。甲醚/氨苯曲明和阿莫西林/克拉维酸是最常寻求的药物。加强国家处方政策,赋予药剂师结构化的处方权,从而促进问责制和合理用药。
{"title":"Prescription-only medicine requests by clients: Insights from community pharmacies","authors":"Chabiya Ayuba Tashiwa ,&nbsp;Erick Wesley Hedima","doi":"10.1016/j.rcsop.2025.100689","DOIUrl":"10.1016/j.rcsop.2025.100689","url":null,"abstract":"<div><h3>Background</h3><div>The accessibility of community pharmacies increases the likelihood that patients will approach pharmacists for medication needs, including those that require prescriptions. This study assessed prescription medicine requests from members of the public. Method This study employed a cross-sectional design to investigate clients seeking medication from community pharmacies in Karu, Nasarawa State, Nigeria. Data were collected using a validated questionnaire comprising of two sections. Chi-square or Fisher's exact tests, where appropriate, were utilized to determine factors associated with prescription-only medicine (POM) requests. Associations between perception scores and patient characteristics were analyzed using the Mann-Whitney <em>U</em> test or Kruskal-Wallis test. Logistic regression analysis was employed to identify factors that may elucidate the correlates of obtaining medicines without a prescription. Statistical significance was set at <em>p</em> &lt; 0.05 (95 % CI).</div></div><div><h3>Results</h3><div>A total of 258 adults with access to prescription-only (POM) or over-thecounter (OTC) medications were included in the study. The prevalence of prescription medicine request was 53 %. Headaches, fever, pain, and dysmenorrhea were the most frequent complaints (33.9 %). A significant difference was observed between medicineseeking practices and chronic illnesses (<em>p</em> = 0.01). The odds of requesting a POM decreased with lower educational attainment (AOR 0.05; 95 % CI, 0.06–0.43). While Age (<em>p</em> = 0.006), employment status (<em>p</em> = 0.03), and monthly income (<em>p</em> = 0.01) were significantly associated with perception of medication-seeking behavior. The most commonly requested medicine was artemether and lumefantrine, accounting for 12.3 % of prescriptions. Most respondents agreed that consultation with a registered medical practitioner for any health concern is necessary.</div></div><div><h3>Conclusion</h3><div>The prevalence of prescription-only medicine requests by clients seeking healthcare from community pharmacies was relatively high. Artemether/lumefantrine and amoxicillin/clavulanate were the most sought medicines. Strengthen national prescribing policies by granting pharmacists structured prescribing authority, thereby promoting accountability and the rational use of medicines.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"21 ","pages":"Article 100689"},"PeriodicalIF":1.8,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145790432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating genetic insights into pain management and opioid use optimization in chronic pain and substance abuse populations 在慢性疼痛和药物滥用人群中整合疼痛管理和阿片类药物使用优化的遗传见解
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-01 DOI: 10.1016/j.rcsop.2025.100684
Ammar Abdulrahman Jairoun , Sabaa Saleh Al-Hemyari , Moyad Shahwan , Abeer M. Al-Ghananeem , Ghala Rashid Alnuaimi , Thantrira Porntaveetus
{"title":"Integrating genetic insights into pain management and opioid use optimization in chronic pain and substance abuse populations","authors":"Ammar Abdulrahman Jairoun ,&nbsp;Sabaa Saleh Al-Hemyari ,&nbsp;Moyad Shahwan ,&nbsp;Abeer M. Al-Ghananeem ,&nbsp;Ghala Rashid Alnuaimi ,&nbsp;Thantrira Porntaveetus","doi":"10.1016/j.rcsop.2025.100684","DOIUrl":"10.1016/j.rcsop.2025.100684","url":null,"abstract":"","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"20 ","pages":"Article 100684"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145680939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers and facilitators for pharmacist-led vaccination services: A systematic review using the Consolidated Framework for Implementation Research (CFIR) 药剂师主导的疫苗接种服务的障碍和促进因素:使用实施研究综合框架(CFIR)的系统综述
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-11-25 DOI: 10.1016/j.rcsop.2025.100687
Meral Abdulselam , Alla El-Awaisi , Ziad G. Nasr , Shahd Shaar , Maguy Saffouh El Hajj

Background

Pharmacists are well positioned to contribute to the expansion of vaccination program outreach, owing to their high accessibility, pharmacotherapy knowledge, and patient-centered services. Over the past decade, the scope of pharmacy practice has progressively evolved, shifting from a product-oriented role toward more direct involvement in public health initiatives, including immunization. Despite this advancement, the full potential of pharmacists as immunization providers remains underutilized due to several barriers.

Objective

This systematic review aims to synthesize evidence on the barriers and facilitators of pharmacist-led vaccination services using the Consolidated Framework for Implementation Research (CFIR).

Method

A comprehensive literature search was conducted across multiple databases (Ovid/Medline, EMBASE, ISI Web of Science, ProQuest Dissertations, PROSPERO, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Elsevier Science Direct, Health Management Information Consortium (HMIC), and Google Scholar. Studies were included if they focused on pharmacist-initiated vaccinations and reported relevant barriers or facilitators. The findings were mapped to CFIR.

Results

A total of 33 studies were included. Barriers to pharmacist-led vaccination services were reported in 32 studies. The main barriers in the Outer Domain were mainly fear of conflicting roles with physicians and public attitudes, lack of physician support, patient unwillingness to receive vaccinations in community settings, liability and regulation related issues, and reimbursement for pharmacist vaccination services. In the Inner Domain, lack of pharmacist training and lack of adequate facilities for delivering community pharmacy vaccination services were the main barriers. Facilitators in the Outer Domain were professional recognition, cooperation between pharmacists and healthcare centers, and financial remuneration. In the Inner Domain, immunization training was frequently considered as a crucial element. Under the Individual Characteristics Domain, opportunities to strengthen the pharmacist–patient relationship, pharmacist interest, patient trust, and patient demand were considered as key facilitators.

Conclusion

This study identified the main barriers and facilitators to pharmacist-led vaccination services using the CFIR framework, primarily within the Outer and Inner Setting domains. Findings highlight the need for targeted training, regulatory support, and reorganized reimbursement. Future research should explore context-specific interventions and evaluate training effectiveness to advance pharmacist-led immunization.
药剂师由于其高可及性、药物治疗知识和以患者为中心的服务,在扩大疫苗接种计划外展方面处于有利地位。在过去十年中,药房的业务范围逐步发展,从以产品为导向的角色转向更直接地参与公共卫生行动,包括免疫接种。尽管取得了这一进展,但由于一些障碍,药剂师作为免疫提供者的全部潜力仍未得到充分利用。目的:本系统综述旨在利用实施研究统一框架(CFIR)综合有关药剂师主导的疫苗接种服务的障碍和促进因素的证据。方法在多个数据库(Ovid/Medline、EMBASE、ISI Web of Science、ProQuest Dissertations、PROSPERO、Cumulative Index to Nursing and Allied Health literature (CINAHL)、Elsevier Science Direct、Health Management Information Consortium (HMIC)和谷歌Scholar)中进行综合文献检索。如果研究的重点是药剂师发起的疫苗接种,并报告了相关的障碍或促进因素,则纳入研究。研究结果被映射到CFIR。结果共纳入33项研究。32项研究报告了药剂师主导的疫苗接种服务存在的障碍。外域的主要障碍主要是害怕与医生的角色冲突和公众态度,缺乏医生的支持,患者不愿意在社区环境中接受疫苗接种,责任和监管相关问题,以及药剂师疫苗接种服务的报销。在内陆地区,缺乏药剂师培训和缺乏提供社区药房疫苗接种服务的适当设施是主要障碍。外域的促进因素包括专业认可、药师与医疗中心的合作以及财务报酬。在内在领域,免疫训练经常被认为是一个关键因素。在个体特征领域,加强医患关系、药师利益、患者信任和患者需求的机会被认为是关键的促进因素。本研究确定了使用CFIR框架的药剂师主导的疫苗接种服务的主要障碍和促进因素,主要是在外部和内部设置领域。研究结果强调了有针对性的培训、监管支持和重组报销的必要性。未来的研究应探索针对具体情况的干预措施,并评估培训效果,以推进药剂师主导的免疫接种。
{"title":"Barriers and facilitators for pharmacist-led vaccination services: A systematic review using the Consolidated Framework for Implementation Research (CFIR)","authors":"Meral Abdulselam ,&nbsp;Alla El-Awaisi ,&nbsp;Ziad G. Nasr ,&nbsp;Shahd Shaar ,&nbsp;Maguy Saffouh El Hajj","doi":"10.1016/j.rcsop.2025.100687","DOIUrl":"10.1016/j.rcsop.2025.100687","url":null,"abstract":"<div><h3>Background</h3><div>Pharmacists are well positioned to contribute to the expansion of vaccination program outreach, owing to their high accessibility, pharmacotherapy knowledge, and patient-centered services. Over the past decade, the scope of pharmacy practice has progressively evolved, shifting from a product-oriented role toward more direct involvement in public health initiatives, including immunization. Despite this advancement, the full potential of pharmacists as immunization providers remains underutilized due to several barriers.</div></div><div><h3>Objective</h3><div>This systematic review aims to synthesize evidence on the barriers and facilitators of pharmacist-led vaccination services using the Consolidated Framework for Implementation Research (CFIR).</div></div><div><h3>Method</h3><div>A comprehensive literature search was conducted across multiple databases (Ovid/Medline, EMBASE, ISI Web of Science, ProQuest Dissertations, PROSPERO, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Elsevier Science Direct, Health Management Information Consortium (HMIC), and Google Scholar. Studies were included if they focused on pharmacist-initiated vaccinations and reported relevant barriers or facilitators. The findings were mapped to CFIR.</div></div><div><h3>Results</h3><div>A total of 33 studies were included. Barriers to pharmacist-led vaccination services were reported in 32 studies. The main barriers in the Outer Domain were mainly fear of conflicting roles with physicians and public attitudes, lack of physician support, patient unwillingness to receive vaccinations in community settings, liability and regulation related issues, and reimbursement for pharmacist vaccination services. In the Inner Domain, lack of pharmacist training and lack of adequate facilities for delivering community pharmacy vaccination services were the main barriers. Facilitators in the Outer Domain were professional recognition, cooperation between pharmacists and healthcare centers, and financial remuneration. In the Inner Domain, immunization training was frequently considered as a crucial element. Under the Individual Characteristics Domain, opportunities to strengthen the pharmacist–patient relationship, pharmacist interest, patient trust, and patient demand were considered as key facilitators.</div></div><div><h3>Conclusion</h3><div>This study identified the main barriers and facilitators to pharmacist-led vaccination services using the CFIR framework, primarily within the Outer and Inner Setting domains. Findings highlight the need for targeted training, regulatory support, and reorganized reimbursement. Future research should explore context-specific interventions and evaluate training effectiveness to advance pharmacist-led immunization.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"21 ","pages":"Article 100687"},"PeriodicalIF":1.8,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Exploratory research in clinical and social pharmacy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1